
                     
                     
                     Drug Interactions
                     
                        
                           
                              Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. Patients receiving anticoagulant therapy require close monitoring, especially when androgens are started or stopped.
                           
                              Oxyphenbutazone: Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
                           
                              Insulin: In diabetic patients, metabolic effects of androgens may decrease blood glucose and insulin requirements.
                        
                     
                     
                  
               